These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

299 related items for PubMed ID: 36371178

  • 1. Molecular subtyping based on TRP family and prognostic assessment for TRP-associated lncRNAs in pancreatic adenocarcinoma.
    Li L, Xiao Z, He P, Zou W, Deng Z, Zhang G, Liu R.
    BMC Gastroenterol; 2022 Nov 12; 22(1):454. PubMed ID: 36371178
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Comprehensive analysis of tumor immune microenvironment and prognosis of m6A-related lncRNAs in gastric cancer.
    Wang Y, Zhu GQ, Tian D, Zhou CW, Li N, Feng Y, Zeng MS.
    BMC Cancer; 2022 Mar 24; 22(1):316. PubMed ID: 35331183
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Comprehensive exploration of immune checkpoint-related genes in the prognosis and tumor immune microenvironment of pancreatic adenocarcinoma.
    Chen X, Zhang H.
    Clinics (Sao Paulo); 2024 Mar 24; 79():100481. PubMed ID: 39208654
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Development and validation of cuproptosis-related lncRNAs associated with pancreatic cancer immune microenvironment based on single-cell.
    Sun Y, Yao L, Man C, Gao Z, He R, Fan Y.
    Front Immunol; 2023 Mar 24; 14():1220760. PubMed ID: 37822927
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. A prospective prognostic signature for pancreatic adenocarcinoma based on ubiquitination-related mRNA-lncRNA with experimental validation in vitro and vivo.
    Wang Z, Yuan Q, Chen X, Luo F, Shi X, Guo F, Ren J, Li S, Shang D.
    Funct Integr Genomics; 2023 Aug 04; 23(3):263. PubMed ID: 37540295
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Construction of a cancer-associated fibroblasts-related long non-coding RNA signature to predict prognosis and immune landscape in pancreatic adenocarcinoma.
    Ye Y, Zhao Q, Wu Y, Wang G, Huang Y, Sun W, Zhang M.
    Front Genet; 2022 Aug 04; 13():989719. PubMed ID: 36212154
    [Abstract] [Full Text] [Related]

  • 13. A novel sphingolipid metabolism-related long noncoding RNA signature predicts the prognosis, immune landscape and therapeutic response in pancreatic adenocarcinoma.
    He X, Xu Z, Ren R, Wan P, Zhang Y, Wang L, Han Y.
    Heliyon; 2024 Jan 15; 10(1):e23659. PubMed ID: 38173505
    [Abstract] [Full Text] [Related]

  • 14. Dissection of pyroptosis-related prognostic signature and CASP6-mediated regulation in pancreatic adenocarcinoma: new sights to clinical decision-making.
    Zhu J, Shi Y, Lan S, Wang J, Jiang F, Tang C, Cai Y, Pan Z, Jian H, Fang H, Zhang Y, Zhong F.
    Apoptosis; 2023 Jun 15; 28(5-6):769-782. PubMed ID: 36882663
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Development and validation of a novel N6-methyladenosine (m6A)-related multi- long non-coding RNA (lncRNA) prognostic signature in pancreatic adenocarcinoma.
    Yuan Q, Ren J, Li L, Li S, Xiang K, Shang D.
    Bioengineered; 2021 Dec 15; 12(1):2432-2448. PubMed ID: 34233576
    [Abstract] [Full Text] [Related]

  • 17. Exploring Unique Extracellular Vesicles Associated Signatures: Prognostic Insights, Immune Microenvironment Dynamics, and Therapeutic Responses in Pancreatic Adenocarcinoma.
    Nan K, Zhang M, Geng Z, Zhang Y, Liu L, Yang Z, Xu P.
    Mediators Inflamm; 2024 Dec 15; 2024():2825971. PubMed ID: 39220187
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Crosstalk of ferroptosis regulators and tumor immunity in pancreatic adenocarcinoma: novel perspective to mRNA vaccines and personalized immunotherapy.
    Shi Y, Wang Y, Dong H, Niu K, Zhang W, Feng K, Yang R, Zhang Y.
    Apoptosis; 2023 Oct 15; 28(9-10):1423-1435. PubMed ID: 37369808
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.